Citadel Advisors’s Zogenix, Inc. ZGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-55,400
Closed -$900K 15323
2021
Q4
$900K Sell
55,400
-8,100
-13% -$119K ﹤0.01% 8216
2021
Q3
$965K Sell
63,500
-266,800
-81% -$4.17M ﹤0.01% 8251
2021
Q2
$5.71M Buy
330,300
+255,700
+343% +$4.71M ﹤0.01% 4151
2021
Q1
$1.46M Sell
74,600
-88,400
-54% -$1.81M ﹤0.01% 7179
2020
Q4
$3.26M Buy
163,000
+84,600
+108% +$1.73M ﹤0.01% 4452
2020
Q3
$1.41M Sell
78,400
-151,900
-66% -$3.72M ﹤0.01% 5393
2020
Q2
$6.22M Sell
230,300
-396,200
-63% -$10.9M ﹤0.01% 2780
2020
Q1
$15.5M Sell
626,500
-171,600
-22% -$6.25M 0.01% 1448
2019
Q4
$41.6M Buy
798,100
+72,100
+10% +$3.3M 0.02% 887
2019
Q3
$29.1M Buy
726,000
+156,500
+27% +$7.21M 0.01% 1151
2019
Q2
$27.2M Buy
569,500
+491,900
+634% +$19.8M 0.01% 1143
2019
Q1
$4.27M Buy
77,600
+9,300
+14% +$443K ﹤0.01% 3230
2018
Q4
$2.49M Sell
68,300
-37,500
-35% -$1.54M ﹤0.01% 3811
2018
Q3
$5.25M Sell
105,800
-105,900
-50% -$5.39M ﹤0.01% 2946
2018
Q2
$9.36M Buy
211,700
+167,700
+381% +$6.91M ﹤0.01% 2015
2018
Q1
$1.76M Sell
44,000
-25,500
-37% -$1.01M ﹤0.01% 3927
2017
Q4
$2.78M Sell
69,500
-153,900
-69% -$5.91M ﹤0.01% 3199
2017
Q3
$7.83M Buy
223,400
+176,200
+373% +$2.39M 0.01% 1844
2017
Q2
$684K Buy
47,200
+16,600
+54% +$209K ﹤0.01% 4667
2017
Q1
$332K Buy
30,600
+16,900
+123% +$171K ﹤0.01% 5744
2016
Q4
$166K Buy
13,700
+1,200
+10% +$13.2K ﹤0.01% 6439
2016
Q3
$143K Buy
12,500
+2,200
+21% +$20.3K ﹤0.01% 6504
2016
Q2
$83K Sell
10,300
-5,300
-34% -$51.7K ﹤0.01% 6271
2016
Q1
$144K Buy
15,600
+3,700
+31% +$37.1K ﹤0.01% 5854
2015
Q4
$175K Sell
11,900
-1,200
-9% -$16.1K ﹤0.01% 5978
2015
Q3
$177K Buy
13,100
+12,475
+1,996% +$225K ﹤0.01% 6310
2015
Q2
$8K Buy
625
+200
+47% +$2.45K ﹤0.01% 8470
2015
Q1
$5K Sell
425
-900
-68% -$10.2K ﹤0.01% 8341
2014
Q4
$15K Buy
1,325
+700
+112% +$6.93K ﹤0.01% 7999
2014
Q3
$6K Buy
+625
New +$7.11K ﹤0.01% 7897

Citadel Advisors's ZGNX Position: Q1 2022 in Review

Citadel Advisors sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 45,210 shares — an estimated $735K sold.

Citadel Advisors first reported a position in ZGNX in Q4 2013 and held it in 25 quarters. The position peaked at $21.9M in Q3 2017. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.

  • Citadel Advisors reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
  • Citadel Advisors sold 45,210 Zogenix, Inc. shares in Q1 2022, an estimated $735K.
  • Citadel Advisors first reported a position in Zogenix, Inc. in Q4 2013 and held it in 25 quarters.
  • Citadel Advisors's Zogenix, Inc. position peaked at $21.9M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.